Gut Microbiome During and after Pelvic Chemoradiation for Gynecologic Cancers
Molly B. El Alam(The University of Texas MD Anderson Cancer Center), Lauren E. Colbert(The University of Texas MD Anderson Cancer Center), Melissa P. Mezzari(Baylor College of Medicine), Nadim J. Ajami(Baylor College of Medicine), Ann H. Klopp(The University of Texas MD Anderson Cancer Center), A.Y. Delgado Medrano(The University of Texas MD Anderson Cancer Center), Lilie L. Lin(The University of Texas MD Anderson Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Anuja Jhingran(The University of Texas MD Anderson Cancer Center), Travis T. Sims(The University of Texas MD Anderson Cancer Center), Patricia J. Eifel(The University of Texas MD Anderson Cancer Center), Greyson Biegert(The University of Texas MD Anderson Cancer Center), Xifeng Wu(Zhejiang Lab), Lois M. Ramondetta(The University of Texas MD Anderson Cancer Center), Kathleen M. Schmeler(The University of Texas MD Anderson Cancer Center), Michael Frumovitz(The University of Texas MD Anderson Cancer Center), Tatiana V. Karpinets(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), K. Court(The University of Texas MD Anderson Cancer Center), Travis Solley(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
October 23, 2020
Cited by 1
Related Papers
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k